A recent study showed that high-dose vitamin C selectively kills colon cancer cells carrying KRAS (KRAS proto-oncogene, GTPase) or BRAF (B-Raf proto-oncogene, serine/threonine kinase) mutations [14]. This evidence concerns the gene KRAS and colonic neoplasm.